Good News: Henan Zhongjie Pharmaceutical’s Dimethicone Emulsion has been officially approved for market launch, and a major nationwide investment promotion initiative is now officially underway!
2025-11-27
Recently, the official website of the National Medical Products Administration announced that the core product of Henan Zhongjie Pharmaceutical—Simethicone Emulsion—has been successfully approved for registration! This achievement provides domestic patients suffering from gastrointestinal bloating with a new, high-quality, domestically produced treatment option and marks another step forward in perfecting the company’s product portfolio in the digestive health sector. We are now launching an extensive investment recruitment campaign nationwide and sincerely invite partners to join us in expanding the market together!
Gastrointestinal bloating is a common digestive discomfort affecting people of all ages, with an incidence rate as high as 30% to 50% in the general population and exceeding 70% among patients with gastrointestinal disorders. The associated symptoms, such as abdominal distension, not only significantly impair patients' quality of life but can also delay postoperative recovery if bloating persists. Moreover, gas bubbles in the intestines can interfere with the clarity of abdominal imaging studies—such as X-rays, ultrasound, and endoscopy—thereby compromising diagnostic accuracy. Simethicone emulsion, a classic clinically proven non-absorbable agent for gastrointestinal disorders, works by physically altering the surface tension of intestinal gas bubbles, facilitating the expulsion of gas and providing rapid relief from abdominal bloating. It does not enter the bloodstream, placing no burden on liver or kidney function, and is suitable for people of all ages. Additionally, it can serve as an adjunctive medication for abdominal imaging studies and as an additive to contrast media suspensions, making it well-suited to meet the needs of various clinical settings.
Henan Zhongjie Pharmaceutical has been deeply engaged in the gastrointestinal field for many years, adhering to the philosophy of "quality first, clinically oriented." The simethicone emulsion recently approved has undergone rigorous research and development validation, achieving a quality and efficacy level that is among the most advanced in China. This product boasts three core advantages: First, it takes effect rapidly—its emulsion formulation ensures uniform dispersion, providing noticeable relief from bloating within 1 to 3 hours; second, it’s highly convenient to use—the 30ml size is perfectly suited for both home and clinical settings, with precise dosage control on the bottle, allowing flexible adjustments for both adults and children, making it hassle-free to administer; third, it offers high safety—free from irritating ingredients and with an extremely low risk of allergic reactions, making it suitable for pregnant and lactating women as well as individuals with impaired liver or kidney function. It can be used across a wide range of scenarios, including gastroenterology, pediatrics, and preoperative preparation in surgery.
As a strategic product in the company’s digestive care segment, the approval of simethicone emulsion further enriches the company’s product portfolio. Relying on a mature production system, stringent quality controls, and a well-established supply chain, this product will meet both clinical and market demands with consistent quality and affordable pricing. Currently, Henan Zhongjie Pharmaceutical is strategically focusing on the field of gastrointestinal health, deeply cultivating niche segments with clinical needs at their core. The recent approval and launch of simethicone emulsion marks an important breakthrough for the company in the symptomatic treatment of gastrointestinal discomfort, laying a solid foundation for the future expansion of its product lineup.
The approval of this new product for launch represents an important step in the company’s commitment to “safeguarding the digestive health of people nationwide.” To accelerate market coverage of our product, we are now officially launching a nationwide recruitment program! We will provide our partners with comprehensive support, including exclusive regional agency protection, flexible supply policies, and stable supply channels, helping them quickly establish a strong market presence.
We sincerely invite pharmaceutical distributors across the country—those with strong capabilities and established channels—to join forces, tap into the enormous potential of the gastrointestinal health market, and jointly create a win-win situation that delivers both commercial and social value!
Previous page:
Real-time news
2026-01-30
Investment Hotline： +86-4001336009
Drug Vigilance Department Contact Hotline：
Address：Xinxiang South Railway Station, Xinxiang City, Henan Province
E-mail：zhongjieyaoye@126.com
Official WeChat
Official Douyin
Copyright © Henan Zhongjie Pharmaceutical Co., Ltd.
Privacy Agreement Supports IPV6 SEO